Diversey

Inotiv, Inc. Announces Changes to its Board Composition

Retrieved on: 
Monday, October 16, 2023
Audit committee, Compensated emancipation, Novartis, Pharmacy, AstraZeneca, Growth, Mars, IPO, Peter Klein (CFO), CFO, Professional Football Compensation Committee, Sale, Management, Diversey

Ms. Coelho is replacing Richard A. Johnson PhD, who is leaving the Board as part of the Board’s succession planning.

Key Points: 
  • Ms. Coelho is replacing Richard A. Johnson PhD, who is leaving the Board as part of the Board’s succession planning.
  • Ms. Coelho was also appointed to serve as a member of the Compensation Committee and the Audit Committee, and as a member and the Chair of the Nominating/Corporate Governance Committee of the Board.
  • Ms. Coelho is the CFO at Gamida Cell Ltd., a public, commercial stage biotech company.
  • She brings extensive experience to the Board as a business leader and senior executive.

Solenis Completes Acquisition of Diversey for $4.6 Billion

Retrieved on: 
Thursday, July 6, 2023
LLP, Bain Capital, Platinum Equity, BofA Securities, Hygiene, Goldman Sachs, Acquisition, Willkie Farr & Gallagher, Gibson Dunn, Platinum, Renewable energy, Security (finance), Diversey, Solenis

WILMINGTON, Del., July 6, 2023 /PRNewswire/ -- Solenis, a leading manufacturer of specialty chemicals used in water-intensive industries, has completed its previously announced acquisition of Diversey Holdings, Ltd., effective July 5, in an all-cash transaction valued at an enterprise value of approximately $4.6 billion. Diversey is a leading provider of hygiene, infection prevention and cleaning products and technology.

Key Points: 
  • With the acquisition, Solenis has grown to an enterprise operating in over 130 countries with 71 manufacturing facilities and more than 15,000 employees.
  • Headquartered in Wilmington, Delaware, Solenis was acquired by Platinum Equity in 2021.
  • Bain Capital, the majority shareholder of Diversey, will hold a minority stake in Solenis as a result of this transaction.
  • Gibson, Dunn & Crutcher LLP provided legal counsel and Willkie Farr & Gallagher LLP provided debt financing counsel to Platinum Equity and Solenis.

Solenis Completes Acquisition of Diversey for $4.6 Billion

Retrieved on: 
Wednesday, July 5, 2023
LLP, Bain Capital, Platinum Equity, BofA Securities, Multimedia, Hygiene, Goldman Sachs, Acquisition, Willkie Farr & Gallagher, Gibson Dunn, Platinum, Tissue paper, Renewable energy, Security (finance), Online shopping, Diversey, Solenis

WILMINGTON, Del., July 5, 2023 /PRNewswire/ -- Solenis, a leading manufacturer of specialty chemicals used in water-intensive industries, has completed its previously announced acquisition of Diversey Holdings, Ltd., effective July 5, in an all-cash transaction valued at an enterprise value of approximately $4.6 billion. Diversey is a leading provider of hygiene, infection prevention and cleaning products and technology.

Key Points: 
  • With the acquisition, Solenis has grown to an enterprise operating in over 130 countries with 71 manufacturing facilities and more than 15,000 employees.
  • Headquartered in Wilmington, Delaware, Solenis was acquired by Platinum Equity in 2021.
  • Bain Capital, the majority shareholder of Diversey, will hold a minority stake in Solenis as a result of this transaction.
  • Gibson, Dunn & Crutcher LLP provided legal counsel and Willkie Farr & Gallagher LLP provided debt financing counsel to Platinum Equity and Solenis.

New Study from Diversey shows that contact time and disinfectant formulation has a significant impact on the efficacies of disinfectant towelettes on hard, non-porous surfaces

Retrieved on: 
Wednesday, June 7, 2023
Scientific Reports, Candida auris, EPA, Diversey Holdings, Disinfectant, Health, Research, Hygiene, Auris, Purdue University, Pharmaceutical industry, Sewage treatment, Diversey

study, selected for its impact on the hygiene and disinfection industry and published in the Scientific Reports journal by Voorn et al.

Key Points: 
  • study, selected for its impact on the hygiene and disinfection industry and published in the Scientific Reports journal by Voorn et al.
  • is part of Diversey's research into disinfection performance to study environmental surfaces and patient care equipment in healthcare facilities.
  • Prior to this research, little was known about disinfectant efficacy against C. auris when wiping larger surfaces, such as would be found in healthcare facilities.
  • The authors tested 5 EPA registered disinfectants on a 1 m2 surface that was intentionally contaminated with C. auris.

New Study from Diversey shows that contact time and disinfectant formulation has a significant impact on the efficacies of disinfectant towelettes on hard, non-porous surfaces

Retrieved on: 
Wednesday, June 7, 2023
Scientific Reports, Candida auris, EPA, Diversey Holdings, Disinfectant, Health, Research, Hygiene, Auris, Purdue University, Pharmaceutical industry, Sewage treatment, Diversey

study, selected for its impact on the hygiene and disinfection industry and published in the Scientific Reports journal by Voorn et al.

Key Points: 
  • study, selected for its impact on the hygiene and disinfection industry and published in the Scientific Reports journal by Voorn et al.
  • is part of Diversey's research into disinfection performance to study environmental surfaces and patient care equipment in healthcare facilities.
  • Prior to this research, little was known about disinfectant efficacy against C. auris when wiping larger surfaces, such as would be found in healthcare facilities.
  • The authors tested 5 EPA registered disinfectants on a 1 m2 surface that was intentionally contaminated with C. auris.

Gamida Cell Appoints Terry Coelho as CFO

Retrieved on: 
Monday, May 22, 2023
Biotechnology, Pharmaceutical, Health, Stem Cells, Bachelor, Therapy, American University School of International Service, Diversey, Mars, DC, First wave, Sealed Air, MBA, Cell, AstraZeneca, Graduate School of Economics and International Relations, Novartis, Boxed warning, Mars, Incorporated, Atmosphere of Earth, Patient, IBMEC, CFO, Collection, Bone marrow, Regulation of tobacco by the U.S. Food and Drug Administration, Hematopoietic stem cell transplantation, Food, Pharmaceutical industry, Management, Economics

Gamida Cell Ltd. (Nasdaq: GMDA), a cell therapy pioneer working to turn cells into powerful therapeutics, today announced the appointment of Terry Coelho as Chief Financial Officer effective immediately.

Key Points: 
  • Gamida Cell Ltd. (Nasdaq: GMDA), a cell therapy pioneer working to turn cells into powerful therapeutics, today announced the appointment of Terry Coelho as Chief Financial Officer effective immediately.
  • Shai Lankry, who has served as the company’s CFO for the past five years, is stepping down as CFO today and will leave the company June 2.
  • “Terry has tremendous experience as CFO of commercial-stage biopharmaceutical companies.
  • “Omisirge has great commercial potential and the opportunity to fill a critical need for patients in need of stem cell transplant,” said Ms. Coelho.

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MMP, DSEY, BGRY

Retrieved on: 
Friday, May 19, 2023
Berkshire Grey, ONEOK, Berkshire, Sale, Diversey, Diversey Holdings, Magellan Midstream Partners, Advertising, Ferdinand Magellan, Fraud, NYSE, Security (finance), Solenis

If you are a Magellan shareholder, click here to learn more about your rights and options .

Key Points: 
  • If you are a Magellan shareholder, click here to learn more about your rights and options .
  • If you are a Diversey shareholder, click here to learn more about your rights and options .
  • Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email [email protected] or [email protected] .
  • Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct.

DIVERSEY HOLDINGS INVESTOR ALERT by The Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Diversey Holdings, Ltd. - DSEY

Retrieved on: 
Thursday, May 18, 2023
Class Action Lawsuit, Professional Services, Legal, KSF, Diversey Holdings, Sale, Diversey, Solenis

and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Diversey Holdings, Ltd. (NasdaqGS: DSEY) to Solenis.

Key Points: 
  • and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Diversey Holdings, Ltd. (NasdaqGS: DSEY) to Solenis.
  • Under the terms of the proposed transaction, shareholders of Diversey will receive $8.40 in cash for each share of Diversey that they own.
  • KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company.
  • To learn more about KSF, whose partners include the Former Louisiana Attorney General, visit www.ksfcounsel.com .

Diversey Reports First Quarter 2023 Results

Retrieved on: 
Thursday, May 4, 2023
Diamond, Plan, Foodservice, General partnership, Securities and Exchange Commission (Nigeria), EBITDA, Acquisition, Water, Security (finance), Proxy, Food, Retail, Diversey, Mergers and acquisitions

Net sales of $218.9 million in the Food & Beverage segment were 16.6% above the first quarter of 2022 or 25.8% when adjusting for currency.

Key Points: 
  • Net sales of $218.9 million in the Food & Beverage segment were 16.6% above the first quarter of 2022 or 25.8% when adjusting for currency.
  • Adjusted EBITDA of $25.7 million increased 16.3% and margin declined 10 basis points compared to the first quarter of 2022.
  • In light of this transaction, as is customary during the pendency of an acquisition, Diversey will not be hosting an earnings conference call or live webcast to discuss its first quarter 2023 financial results and Diversey will not be providing guidance for 2023.
  • For further details and discussion of our financial performance please refer to our Form 10-Q for the quarter ended March 31, 2023.

SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates ROCC, RADI, KBAL, DSEY

Retrieved on: 
Tuesday, April 18, 2023
Kimball International, HNI, Sale, Diversey, Ranger Oil Corporation, Diversey Holdings, Primary energy, EQT, Advertising, HNI Corporation, Fenthion, Fraud, Security (finance), Ranger, Solenis

If you are a Ranger shareholder, click here to learn more about your rights and options .

Key Points: 
  • If you are a Ranger shareholder, click here to learn more about your rights and options .
  • If you are a Radius shareholder, click here to learn more about your rights and options .
  • Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email [email protected] or [email protected] .
  • Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct.